Is this you? Create Your Porfile
Avatar

Hong Woon Yang

AstraZeneca

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Hong Woon Yang is active.

Explore More

Publication

Featured researches published by Hong Woon Yang.

Archive | 2004

Heterocyclic inhibitors of mek and methods of use thereof

Allison L. Marlow; Eli M. Wallace; Jeongbeob Seo; Joseph P. Lyssikatos; Hong Woon Yang; James Blake

Archive | 2004

Bicyclic inhibitors of mek and methods of use thereof

Eli M. Wallace; Hong Woon Yang; James Blake

Archive | 2005

Method of treating inflammatory diseases

Kevin Koch; T. Brian Hurley; Hong Woon Yang; Joseph P. Lyssikatos; James Blake; Allison L. Marlow; Eli M. Wallace

Journal of Medicinal Chemistry | 2006

Potent and Selective Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors. 1. 4-(4-Bromo-2-fluorophenylamino)-1- methylpyridin-2(1H)-ones

Eli M. Wallace; Joseph P. Lyssikatos; James F. Blake; Jeongbeob Seo; Hong Woon Yang; Tammie Yeh; Michele Perrier; Heidi Jarski; Vivienne Marsh; Gregory Poch; Michelle Goyette Livingston; Jennifer Otten; Gary P. Hingorani; Rich Woessner; Patrice Lee; James D. Winkler; Kevin M. Koch

Archive | 2012

Bicyclic inhibitors of mek

Eli M. Wallace; Hong Woon Yang; Jim Blake

Archive | 2006

Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof

Allison L. Marlow; Eli M. Wallace; Jeongbeob Seo; Joseph P. Lyssikatos; Hong Woon Yang; James Blake

Archive | 2012

Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof

Allison L. Marlow; Eli M. Wallace; Jeongbeob Seo; Joseph P. Lyssikatos; Hong Woon Yang; James F. Blake

Archive | 2006

Method of treating hyperproliferative disorders using heterocyclic inhibitors of MEK

Eli M. Wallace; Hong Woon Yang; Jim Blake

Archive | 2006

4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as MEK inhibitors for the treatment of hyperproliferative diseases

Richard Anthony Storey; Rebecca Jane Booth; John David Pittam; John Leonard; Mark Richard Fielding; Allison L. Marlow; Eli Wallace; Jeongbeob Seo; Joseph P. Lyssikatos; Hong Woon Yang; James Blake

Archive | 2011

Substituted pyridazines inhibitors of MEK

Allison L. Marlow; Eli M. Wallace; Jeongbeob Seo; Joseph P. Lyssikatos; Hong Woon Yang; James F. Blake

Explore More

Collaboration

Dive into the Hong Woon Yang's collaboration.

Top Co-Authors
Avatar

Eli M. Wallace

Novartis

View shared research outputs
Top Co-Authors
Avatar

Joseph P. Lyssikatos

University of California

View shared research outputs
Top Co-Authors
Avatar

Jeongbeob Seo

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Allison L. Marlow

Anschutz Medical Campus

View shared research outputs
Top Co-Authors
Avatar

Jim Blake

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

John David Pittam

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

John Leonard

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Mark Richard Fielding

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Rebecca Jane Booth

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Richard Anthony Storey

AstraZeneca

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge